Related Experiment Video
Updated: Jun 3, 2026
09:57
Induced Pluripotent Stem Cell Generation from Blood Cells Using Sendai Virus and Centrifugation
Published on: December 21, 2016
Potential clinical applications for human pluripotent stem cell-derived blood components
1Stem Cell & Regenerative Medicine International, 33 Locke Drive, Marlborough, MA 01752, USA.
Stem Cells International
|March 26, 2011
Summary
Human embryonic stem cells (hESCs) and induced pluripotent stem cells (iPSCs) show promise for regenerative medicine. Their derivatives are being explored as functional blood cell replacements, though clinical application requires further research.
Area of Science:
- Stem cell biology
- Regenerative medicine
- Hematology
Background:
- Human embryonic stem cells (hESCs) and induced pluripotent stem cells (iPSCs) possess unlimited self-renewal and pluripotency.
- Adult stem cell therapies for blood disorders provide a precedent for hESC/iPSC applications.
- Understanding mature blood cell functions and clinical needs is crucial for developing stem cell-based therapies.
Purpose of the Study:
- To review the potential of hESC/iPSC derivatives as functional replacements for blood cells.
- To highlight biological functions of mature blood cells and clinical conditions requiring their intervention.
- To assess the progress and challenges in generating clinical-grade blood components from hESCs and iPSCs.
Main Methods:
- Review of existing literature on hESC/iPSC differentiation into blood cell types.
- Analysis of functional capabilities of differentiated blood cells in vitro.
- Evaluation of clinical requirements for blood cell therapies.
Main Results:
- hESCs and iPSCs can be differentiated into various mature blood cell types.
- hESC-derived red blood cells and platelets demonstrate functional oxygen delivery and clotting capabilities.
- hESC-derived dendritic cells show potential for cancer vaccine therapies.
Conclusions:
- hESC/iPSC-derived blood components offer potential for regenerative medicine and emergency transfusion.
- Further optimization of in vitro differentiation systems is necessary for clinical translation.
- Stem cell-derived blood products hold promise for treating hematologic conditions and cancer.
More Related Videos
12:03Generation of Human Induced Pluripotent Stem Cells from Peripheral Blood Using the STEMCCA Lentiviral Vector
Published on: October 31, 2012
13:13High Efficiency Differentiation of Human Pluripotent Stem Cells to Cardiomyocytes and Characterization by Flow Cytometry
Published on: September 23, 2014
Related Concept Videos
01:17Stem Cell Culture
Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
01:13Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
01:06Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Somatic cells are...
01:13Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
01:22iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
00:58Embryonic Stem Cells
Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.